• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗结核药物与正常血清和夸希奥科病血清的结合。

The binding of antituberculous drugs to normal and kwashiorkor serum.

作者信息

Buchanan N, van der Walt L A

出版信息

S Afr Med J. 1977 Sep 17;52(13):522-5.

PMID:918794
Abstract

The protein binding of 6 antituberculous drugs--ethambutol, ethionamide, isoniazid, para-aminosalicylic acid, rifampicin and streptomycin--to normal and kwashiorkor serum has been investigated. The binding of these drugs was mildly decreased in kwashiorkor serum, but not to such an extent as to be of therapeutic importance, except for streptomycin and possibly para-aminosalicylic acid (PAS). With streptomycin there was a 15% increase in the free component in kwashiorkor serum, while with PAS there was a 12% increase in the free component. Of interest is the observation that rifampicin is predominantly bound to the gamma-globulin fraction, both in normal and in kwashiorkor serum. Secondary binding, predominantly to the alpha 1-, alpha 2-and gamma-globulin fractions, was seen quite commonly in kwashiorkor serum in association with diminished albumin binding.

摘要

已对六种抗结核药物——乙胺丁醇、乙硫异烟胺、异烟肼、对氨基水杨酸、利福平和链霉素——与正常血清和夸休可尔症血清的蛋白结合情况进行了研究。在夸休可尔症血清中,这些药物的结合略有减少,但除链霉素以及可能的对氨基水杨酸(PAS)外,减少程度未达到具有治疗重要性的水平。对于链霉素,夸休可尔症血清中的游离成分增加了15%,而对于PAS,游离成分增加了12%。有趣的是,观察发现利福平在正常血清和夸休可尔症血清中均主要与γ-球蛋白部分结合。在夸休可尔症血清中,由于白蛋白结合减少,常可见到主要与α1-、α2-和γ-球蛋白部分结合的二级结合。

相似文献

1
The binding of antituberculous drugs to normal and kwashiorkor serum.抗结核药物与正常血清和夸希奥科病血清的结合。
S Afr Med J. 1977 Sep 17;52(13):522-5.
2
[Determinations of concentration of tuberculostatics].[抗结核药浓度的测定]
Tidsskr Nor Laegeforen. 1974 Dec 10;94(34-36):2394-5.
3
Clinical pharmacokinetics of the antituberculosis drugs.抗结核药物的临床药代动力学。
Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.
4
[Binding of serum proteins to tuberculostatics].[血清蛋白与抗结核药的结合]
Z Tuberk. 1956;109(3):142-50.
5
The binding of phenobarbitone and phenytoin to kwashiorkor serum.
S Afr Med J. 1977 Sep 17;52(13):518-21.
6
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
7
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].[使用³²P掺入试验测定结核分枝杆菌对异烟肼、链霉素、对氨基水杨酸、乙硫异烟胺、乙胺丁醇和利福平的耐药性]
Acta Biol Med Ger. 1973;30(3):309-16.
8
[Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].[新型抗结核药物——利福平与乙胺丁醇对肺结核患者的抑菌活性及血药浓度的研究]
Antibiotiki. 1971 May;16(5):472-7.
9
[Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid].[在异烟肼存在的情况下,使用琼脂扩散法分别测定血液中链霉素和利福平的浓度]
Antibiotiki. 1982 Mar;27(3):173-6.
10
[Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].两例对氨基水杨酸(PAS)诱发甲状腺功能减退的耐多药肺结核病例
Kekkaku. 2001 Oct;76(10):667-72.

引用本文的文献

1
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis.利福平与蛋白在结核性脑膜炎患儿配对的脊髓与脑室脑脊液样本中的浓度。
J Antimicrob Chemother. 2024 Feb 1;79(2):280-286. doi: 10.1093/jac/dkad371.
2
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.群体药代动力学与贝叶斯剂量调整推进抗结核药物治疗药物监测。
Clin Pharmacokinet. 2021 Jun;60(6):685-710. doi: 10.1007/s40262-021-00997-0. Epub 2021 Mar 6.
3
Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials.
基于模型的利福平暴露与印尼结核性脑膜炎试验死亡率的荟萃分析。
Clin Infect Dis. 2020 Nov 5;71(8):1817-1823. doi: 10.1093/cid/ciz1071.
4
Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.利福平血浆蛋白结合在结核病患者治疗中的临床意义
Clin Pharmacokinet. 2019 Dec;58(12):1511-1515. doi: 10.1007/s40262-019-00800-1.
5
Protein Binding of First-Line Antituberculosis Drugs.一线抗结核药物的蛋白结合率。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00641-18. Print 2018 Jul.
6
A systematic review of pharmacokinetics studies in children with protein-energy malnutrition.蛋白质-能量营养不良儿童的药代动力学研究系统评价。
Eur J Clin Pharmacol. 2010 Oct;66(10):1025-35. doi: 10.1007/s00228-010-0851-0. Epub 2010 Jun 16.
7
Clinical pharmacokinetics of the antituberculosis drugs.抗结核药物的临床药代动力学。
Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.